Lecanda et al. 2016 (PRJNA330982)

General Details

Title Dual randomization of oligonucleotides to reduce the bias in ribosome-profiling libraries
Organism
Number of Samples 13
Release Date 2016/07/22 00:00
Sequencing Types
Protocol Details

Study Links

Repository Details

SRA SRP079402
ENA SRP079402
GEO GSE84746
BioProject PRJNA330982

Publication

Title
Authors Lecanda A,Nilges BS,Sharma P,Nedialkova DD,Schwarz J,Vaquerizas JM,Leidel SA
Journal Methods (San Diego, Calif.)
Publication Date 2016 Sep 1
Abstract Protein translation is at the heart of cellular metabolism and its in-depth characterization is key for many lines of research. Recently, ribosome profiling became the state-of-the-art method to quantitatively characterize translation dynamics at a transcriptome-wide level. However, the strategy of library generation affects its outcomes. Here, we present a modified ribosome-profiling protocol starting from yeast, human cells and vertebrate brain tissue. We use a DNA linker carrying four randomized positions at its 5' end and a reverse-transcription (RT) primer with three randomized positions to reduce artifacts during library preparation. The use of seven randomized nucleotides allows to efficiently detect library-generation artifacts. We find that the effect of polymerase chain reaction (PCR) artifacts is relatively small for global analyses when sufficient input material is used. However, when input material is limiting, our strategy improves the sensitivity of gene-specific analyses. Furthermore, randomized nucleotides alleviate the skewed frequency of specific sequences at the 3' end of ribosome-protected fragments (RPFs) likely resulting from ligase specificity. Finally, strategies that rely on dual ligation show a high degree of gene-coverage variation. Taken together, our approach helps to remedy two of the main problems associated with ribosome-profiling data. This will facilitate the analysis of translational dynamics and increase our understanding of the influence of RNA modifications on translation. Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.
PMC PMC5024760
PMID 27450428
DOI
Run Accession Study Accession Scientific Name Cell Line Library Type Treatment GWIPS-viz Trips-Viz Reads BAM BigWig (F) BigWig (R)
SRR3945920 PRJNA330982 Saccharomyces cerevisiae Ribo-Seq Cycloheximide
SRR3945921 PRJNA330982 Saccharomyces cerevisiae Ribo-Seq Cycloheximide
SRR3945922 PRJNA330982 Saccharomyces cerevisiae Ribo-Seq Cycloheximide
SRR3945923 PRJNA330982 Saccharomyces cerevisiae Ribo-Seq Cycloheximide
SRR3945924 PRJNA330982 Saccharomyces cerevisiae Ribo-Seq Cycloheximide
SRR3945925 PRJNA330982 Saccharomyces cerevisiae Ribo-Seq Cycloheximide
SRR3945926 PRJNA330982 Saccharomyces cerevisiae Ribo-Seq Cycloheximide
SRR3945927 PRJNA330982 Saccharomyces cerevisiae Ribo-Seq Cycloheximide
SRR3945928 PRJNA330982 Saccharomyces cerevisiae Ribo-Seq Cycloheximide
SRR3945929 PRJNA330982 Saccharomyces cerevisiae Ribo-Seq Cycloheximide
SRR3945930 PRJNA330982 Saccharomyces cerevisiae Ribo-Seq Cycloheximide
SRR3945931 PRJNA330982 Saccharomyces cerevisiae Ribo-Seq Cycloheximide
SRR3945932 PRJNA330982 Saccharomyces cerevisiae Ribo-Seq Cycloheximide
Run Accession Study Accession Scientific Name Cell Line Library Type Treatment GWIPS-viz Trips-Viz Reads BAM BigWig (F) BigWig (R)

ⓘ For more Information on the columns shown here see: About